Search Results 401-410 of 14948 for Virulence

  1. Lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this cancer of the lymphatic system.

  2. A Study of the Effectiveness and Safety of Rivaroxaban on Venous Thromboembolic Risk in Patients Following Hospital Discharge - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Circulating Tumor Cells in Patients with Cholangiocarcinoma - Mayo Clinic

    About this study. The overall goal of this research is to measure the circulating tumor cell in the peripheral blood and investigate the association between ...

  4. Brain tumor - Doctors and departments - Mayo Clinic

    Learn about our team of brain tumor doctors and surgeons who are researching new ways of diagnosing and treating this condition.

  5. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

    About this study. This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia ...

  6. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Learn about this rare tumor that forms in the salivary glands. Treatments include surgery and radiation therapy.

  7. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  8. Brain tumor - Doctors and departments - Mayo Clinic

    Learn about our team of brain tumor doctors and surgeons who are researching new ways of diagnosing and treating this condition.

  9. A Study to Evaluate Quality of Life, Psychological Impact, and End Organ Damage in Survivors of Severe Drug Eruptions - Mayo Clinic

    About this study. The purpose of this study is to determine the extent to which patients who survive severe drug eruptions suffer long-term end organ damage ...

  10. ShortStop-HER2: 12 Months Vs. 6 Months Of HER2-targeted Medications For People With HER2+ Breast Cancer Who Had A Pathologic Complete Response After Chemotherapy Plus Trastuzumab - Mayo Clinic

    Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer ...